Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma
暂无分享,去创建一个
M. Tsuneyoshi | M. Shimada | K. Sugimachi | S. Aishima | K. Taguchi | S. Tanaka | Masazumi Tsuneyoshi | Shinji Tanaka | K. Taguchi | Mitsuo Shimada
[1] A. Harris,et al. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia , 2002, The Journal of pathology.
[2] J. Le Bas,et al. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain. , 2002, Anticancer research.
[3] K. Sugimachi,et al. Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma , 2002, Hepatology.
[4] L. Ellis,et al. Differential expression of angiopoietin‐1 and angiopoietin‐2 in colon carcinoma , 2001, Cancer.
[5] T. Suda,et al. Role for Angiogenesis Expression of Angiopoietin-2 in Human Glioma Cells and Its Updated Version , 2001 .
[6] K. Alitalo,et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. , 2001, Cardiovascular research.
[7] Andrew L. Kung,et al. Suppression of tumor growth through disruption of hypoxia-inducible transcription , 2000, Nature Medicine.
[8] Ji-Hye Kim,et al. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway , 2000, Oncogene.
[9] G. Krikun,et al. Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. , 2000, Biochemical and biophysical research communications.
[10] G. Semenza,et al. HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.
[11] H. Dvorak,et al. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. , 2000, The American journal of pathology.
[12] B. Bussolati,et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. , 2000, The American journal of pathology.
[13] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[14] G. Yancopoulos,et al. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.
[15] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[16] K. Suzuma,et al. Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells* , 1999, The Journal of Biological Chemistry.
[17] M. Makuuchi,et al. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. , 1999, The Journal of clinical investigation.
[18] K. Plate,et al. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. , 1998, The American journal of pathology.
[19] M. Kojiro,et al. Expression of vascular endothelial growth factor in human hepatocellular carcinoma , 1998, Hepatology.
[20] Douglas Hanahan,et al. Signaling Vascular Morphogenesis and Maintenance , 1997, Science.
[21] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[22] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[23] J. Gleadle,et al. Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. , 1997, Blood.
[24] Pamela F. Jones,et al. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.
[25] Pamela F. Jones,et al. Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.
[26] K. Shirabe,et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. , 1996, Gastroenterology.
[27] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[28] H. Honda,et al. CD34 expression in endothelial cells of small hepatocellular carcinoma: Its correlation with tumour progression and angiographic findings , 1995, Journal of gastroenterology and hepatology.
[29] Thomas N. Sato,et al. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Hirohashi,et al. Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma. , 1993, Japanese journal of clinical oncology.
[31] J. Rossant,et al. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. , 1992, Oncogene.
[32] J. Partanen,et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains , 1992, Molecular and cellular biology.
[33] K. Shirabe,et al. Angiographically undetected small hepatocellular carcinoma: Clinicopathological characteristics, follow‐up and treatment , 1989, Hepatology.
[34] R. Macsween. Pathology of the Liver , 1981 .
[35] H. Naora,et al. Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway. , 2002, Anticancer research.
[36] Zheng Qi-chang. Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma , 2001 .
[37] W. Risau,et al. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the Angiopoietin receptor Tie-2 , 1999, Oncogene.
[38] P. Rao,et al. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. , 1998, British Journal of Cancer.
[39] 日本肝癌研究会. Classification of primary liver cancer , 1997 .
[40] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[41] Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. , 1990, Annals of surgery.
[42] W. G. Hardy,et al. Vascular disorders. , 1968, Progress in neurology and psychiatry.